JWCA
IDXX icon

J.W. Cole Advisors’s Idexx Laboratories IDXX Stock Holding History

J.W. Cole Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Buy
4,970
+81
+2% +$45.4K 0.04% 412
2026
Q1 		$2.75M Buy
4,889
+36
+0.7% +$23.1K 0.09% 193
2025
Q4 		$2.97M Buy
4,853
+242
+5% +$165K 0.07% 271
2025
Q3 		$2.95M Buy
4,611
+177
+4% +$107K 0.06% 335
2025
Q2 		$2.38M Buy
4,434
+440
+11% +$210K 0.05% 358
2025
Q1 		$1.68M Buy
3,994
+1,234
+45% +$536K 0.05% 368
2024
Q4 		$1.14M Buy
2,760
+118
+4% +$51.8K 0.05% 379
2024
Q3 		$1.33M Buy
2,642
+1,310
+98% +$636K 0.06% 327
2024
Q2 		$649K Buy
+1,332
New +$669K 0.03% 448
2020
Q4 		– Sell
-2,490
Closed -$979K – 748
2020
Q3 		$979K Buy
+2,490
New +$921K 0.08% 255

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

J.W. Cole Advisors's IDXX Position: Q2 2026 in Review

J.W. Cole Advisors increased its Idexx Laboratories (IDXX) stake by 1.7% in Q2 2026, buying an estimated $45.4K and bringing the position to 4,970 shares worth $2.62M. The position accounts for 0.04% of the portfolio, ranked #412.

J.W. Cole Advisors first reported a position in IDXX in Q3 2020 and has held it in 10 quarters since. The position peaked at $2.97M in Q4 2025. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • J.W. Cole Advisors held 4,970 shares of Idexx Laboratories worth $2.62M as of Q2 2026.
  • J.W. Cole Advisors bought 81 Idexx Laboratories shares in Q2 2026, an estimated $45.4K.
  • Idexx Laboratories made up 0.04% of J.W. Cole Advisors's portfolio in Q2 2026, its #412 holding.
  • J.W. Cole Advisors first reported a position in Idexx Laboratories in Q3 2020 and has held it in 10 quarters since.
  • J.W. Cole Advisors's Idexx Laboratories position peaked at $2.97M in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.